Influence of non-insulin-dependent diabetes mellitus on plasma endothelin-1 levels in patients with advanced atherosclerosis

Journal of Diabetes and its Complications

Volumn 12, Issue 4, 1998, Pages 187-192

  Perfetto, F ^a   Tarquini, R ^a   Tapparini, L ^a   Tarquini, B ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1;

ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PATHOGENESIS; PRIORITY JOURNAL; VASCULAR DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ARTERIOSCLEROSIS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ENDOTHELIN-1; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 0031779261     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(97)00092-5     Document Type: Article

References (46)

1. Ross R. The pathogenesis of atherosclerosis-an update. N Engl J Med. 314:1986;488-500.
2. Lerman A., Holmes J.R., Bell M.R., Garrant K.N., Nishimura R.A., Burnett J.C. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation. 92:1995;2426-2431.
3. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.
4. Yanagisawa M., Masaki T. Molecular biology and biochemistry of the endothelins. Trends Pharmacol Sci. 10:1989;374-378.
5. Hasdai D., Holmes D.R., Garrat K.N., Edwards W.D., Lerman A. Mechanical pressure and stretch release endothelin-1 from human atherosclerotic coronary artery in vivo. Circulation. 95:1997;357-362.
6. Schini V.B., Hendrickson H., Heublein D. Thrombin enhances the release of endothelin from cultured porcine aortic endothelial cells. Eur J Pharmacol. 165:1989;333-334.
7. Boulanger C., Luscher T.F. Nitric oxide and hirudin inhibit the thrombin-stimulated release of endothelin from the intact porcine aorta by two different mechanisms. Circ Res. 68:1991;1768-1772.
8. Kurihara H., Yoshizumi M., Sugihama T., Takaku F., Yanagisawa M., Masaki T., Hamaoki M., Kato H., Yazaki Y. Transforming growth factor-β stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun. 159:1989;1435-1440.
9. Maemura K., Kurihara H., Morita T., Ohhashi Y., Yazaki Y. Production of endothelin-1 in vascular endothelial cells is regulated by factors associated with vascular injury. Gerontology. 38:1992;29-35.
10. Lüscher T.F. Endothelin. systemic arterial and pulmonary effects of a new peptide with potent biological properties Am Rev Respir Dis. 146:1992;S56-S60.
11. Dubin D., Pratt R.E., Cooke J.P., Dzau V.J. Endothelin, a potent vasoconstrictor, is a vascular smooth muscle mitogen. J Vasc Med Biol. 1:1989;150-154.
12. Hirata Y., Takagi Y., Fukuda Y., Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis. 78:1989;225-228.
13. Takagi Y., Fukase M., Takata S., Yoshimi H., Tokunaga O., Fujita T. Autocrine effect of endothelin on DNA synthesis on human vascular endothelial cells. Biochem Biophys Res Commun. 168:1990;537-543.
14. Mayauchi T., Yanagisawa M., Tomizaua T., Sugihita Y., Suzuki N., Fujino M., Ajisaka R., Goto K., Masaki K. Increased plasma concentration of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet. 1:1989;5-8.
15. Saito Y., Nakao K., Mukoyama M., Imura H. Increased plasma endothelin level in patients with essential hypertension. N Engl J Med. 322:1990;321-325.
16. Stewart D.J., Levy R.D., Cernacek P., Langleben D. Increased plasma endothelin-1 in pulmonary hypertension. marker or mediator of disease? Ann Intern Med. 114:1991;464-469.
17. Giad A., Yanagisawa M., Langleben D., Michel R.P., Levy R., Shennib H., Kimura S., Masaki T., Duguid W.P., Path F.R.C., Stewart D.J. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med. 328:1993;1732-1739.
18. Lerman A., Edwards B.S., Hallet J.W., Heublein D.M., Sandberg S.M., Burnet J.C. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med. 325:1991;997-1001.
19. Koyama H., Nishzawa Y., Moril H., Tabata T., Inoue T., Yamaji T. Plasma endothelin levels in patients with uremia. Lancet. 1:1989;991-993.
20. Tomita K., Ojile K., Nakanishi T., Tomura S., Matsuda O., Ando K., Shichiri M., Hirata Y., Marumo F. Plasma endothelin levels in patients with acute renal failure. N Engl J Med. 321:1989;1127-1130.
21. Pyorala K., Laakso M., Uhsitupsam M. Diabetes and atherosclerosis. An epidemiologic view Diabetes Metab Rev. 3:1987;463-524.
22. Kannel W.B., McGee K.I. Diabetes and cardiovascular disease. The Framingham study JAMA. 241:1979;2035-2038.
23. Perfetto F., Tarquini R., de Leonardis V., Piluso A., Lombardi V., Tarquini B. Angiopathy affects circulating endothelin-1 levels in type 2 diabetic patients. Acta Diabetol. 32:1995;263-267.
24. Tarquini B., Perfetto F., Tarquini R., Cornelissen G., Halberg F. Endothelin-1 chronome indicates diabetes and vascular disease chronorisk. Peptides. 18:1997;119-132.
25. Tarquini B, Cornelissen G, Perfetto F, Tarquini R, Halberg F: About-half-weekly (circasemiseptan) component of the endothelin-1 chronome and vascular disease risk. Peptides 1998 (in press).
26. Takahashi K., Ghatei M.A., Lam H.C., O'Halloran D.J., Bloom S.R. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia. 33:1990;306-310.
27. Veglio F., Bertello P., Pinna G., Mulatero P., Rossi A., Gurioli L., Panarelli M., Chiandussi L. Plasma endothelin in essential hypertension and diabetes mellitus. J Hum Hypertens. 7:1993;321-325.
28. Kawamura M., Ohgawara H., Naruse M., Suzuki N., Iwasaky N., Naruse K., Hori S., Demura H., Omori Y. Increased plasma endothelin in NIDDM patients with retinopathy. Diabetes Care. 15:1992;1396-1397.
29. Collier A., Leach J.P., McLellan A., Jardine A., Morton J.J., Small M. Plasma endothelinlike immunoreactivity levels in NIDDM patients with microalbuminuria. Diabetes Care. 15:1992;1038-1040.
30. Haak T., Jungmann E., Felber A., Hillmann U., Usadel K.H. Increased plasma levels of endothelin in diabetic patients with hypertension. Am J Hypertens. 5:1992;161-166.
31. Bath P.M., Martin J.F. Serum platelet-derived growth factor and endothelin concentrations in human hypercolesterolemia. J Intern Med. 230:1991;313-317.
32. Helset E., Sildnes T., Seljelid R., Konoposki Z.S. Endothelin-1 stimulates human monocytes in vitro to release TNF-alpha, IL-1beta and IL-6. Mediat Inflammation. 2:1993;417-422.
33. Helset E., Sildnes T., Konoposki Z.S. Endothelin-1 stimulates monocytes in vitro to release chemotactic activity identified as interleukin-8 and monocyte chemotactic protein-1. Mediat Inflammation. 3:1994;155-160.
34. Magazine H.I., Andersen T.T., Bruner C.A., Malik A.B. Vascular contractile potency of endothelin-1 is increased in the presence of monocytes or macrophages. Am J Physiol. 366:1994;H1620-H1625.
35. Bacon C.R., Nathaniel R.B., Davenport A.P. Endothelin peptide and receptors in human atherosclerotic coronary artery and aorta. Circ Res. 79:1996;794-801.
36. Jones G.T., von Rij A.M., Solomon C., Thomson I.A., Parker S.G.K. Endothelin-1 is increased overlying atherosclerotic plaques in human arteries. Atherosclerosis. 24:1996;25-35.
37. Boulanger C.M., Tanner F.C., Bea M.L., Hahn A.W.A., Werner A., Luscher T.F. Oxidized low-density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res. 70:1992;1191-1197.
38. Winkles J.A., Alberts G.F., Brogi E., Libby P. Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries. Biochem Biophys Res Commun. 191:1993;1081-1088.
39. Boulanger C.M., Lüscher T.F. Release of endothelin from the porcine aorta. Inhibition by endothelium derived nitric oxide J Clin Invest. 85:1990;587-590.
40. Resink T.J., Hahn A.W.A., Scott-Burden T., Powell J., Weber E., Buhler F.R. Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells. Biochem Biophys Res Commun. 168:1990;1303-1310.
41. Hu R.-M., Levin E.R., Pedram A., Frank H.J.L. Insulin stimulates the production and secretion of endothelin from bovine endothelial cells. Diabetes. 42:1993;351-358.
42. Hattori Y., Kasai K., Nakamura T., Emoto T., Shimoda S.-I. Effect of glucose and insulin on immunoreactive endothelin-1 release from cultured porcine aortic endothelial cells. Metabolism. 40:1991;165-169.
43. Oliver F.J., de la Rubia G., Feener E.P., Lee M.-E., Loeken M.R., Shiba T., Quertermous T., King G.L. Stimulation of endothelin-1 gene expression by insulin in endothelial cells. J Biol Chem. 266:1991;23251-23256.
44. Frank H.J.L., Leven E.R., Hu R.-M., Pedram A. Insulin stimulates endothelin biding and action on cultured vascular smooth muscle cells. Endocrinology. 133:1993;1092-1097.
45. Ferri C., Bellini C., Laurenti O. Insulin modulates circulating endothelin-1 levels in humans. Am J Hypertens. 7:1994;69A.
46. Piatti P.M., Monti D.L., Conti M., Baruffaldi L., Galli L., Pitan C.V., Guazzini B., Pontiroli E., Pozza G. Hypertriglyceridemia and hyperinsulinemia are potent inducers of endothelin-1 release in humans. Diabetes. 45:1996;316-321.